Replies to post #116946 on Biotech Values

[DewDiligence]

William Lis, chief executive of Portola, said the company plans to discuss ways to pursue development of betrixaban with the FDA and with academic partners.

Since when does the FDA offer advice in business development?

http://online.wsj.com/article/SB10001424052748704425804576220523004764308.html